Related Experiment Videos
Abstract:
This review summarizes recent work that focuses on the role of endogenous opioids (EOs) and opiate receptors in the control of food intake. Although the anorexic effect of opiate antagonists are now well accepted, the exact EO, site(s), and mechanism(s) of action remain to be established. However, accumulating evidence suggests that dynorphin, an endogenous ligand for kappa-type opiate receptors, is an important regulator (stimulant) of appetite. The roles of other EOs, such as beta-endorphin, are less clear. EOs appear to be involved in maintaining normal feeding behavior and are likely responsible for the overconsumption of fat in genetically obese and stressed subjects. Opiate antagonists block overconsumption of palatable foods, thus offering a promising approach to weight reduction for some overweight individuals. Anorexias may follow from a deficiency of kappa-type opioid activity, and surprisingly, can also result from excess opioid activity. Indeed, opiate antagonists of the mu type (naloxone) can enhance eating and weight gain in certain anorexic conditions. Therefore, it appears that excess opioid agonist activity may result in hyperphagia or anorexia (depending on the opiate receptor type). Finally, opiate antagonists may help normalize both types of pathological feeding states.
Insights
Endogenous opioids (EOs) and opiate receptors significantly influence food intake. Opiate antagonists show promise for weight reduction by blocking overconsumption of palatable foods.
Area of Science:
- Neuroscience
- Behavioral Science
- Pharmacology
Background:
- Endogenous opioids (EOs) and their receptors play a crucial role in regulating food intake.
- While the anorexic effects of opiate antagonists are recognized, the precise EOs, sites, and mechanisms involved are still under investigation.
- Dynorphin, a kappa-type opiate receptor ligand, is increasingly implicated as a key appetite stimulant.
Purpose of the Study:
- To review recent research on the involvement of endogenous opioids and opiate receptors in controlling food intake.
- To explore the potential of opiate antagonists in managing appetite and weight.
- To elucidate the complex roles of various EOs in feeding behavior and pathological states.
Main Methods:
- Review of existing scientific literature focusing on endogenous opioids and food intake.
- Analysis of studies investigating the effects of opiate antagonists on appetite and food consumption.
- Examination of evidence linking specific opioid pathways (e.g., kappa, mu) to feeding regulation.
Main Results:
- Accumulating evidence points to dynorphin as a significant appetite stimulant.
- EOs are involved in normal feeding and may contribute to overconsumption of fats in obese or stressed individuals.
- Opiate antagonists effectively block the overconsumption of palatable foods, suggesting a role in weight management.
- Both deficiency and excess of kappa-type opioid activity can lead to anorexia.
- Mu-type opiate antagonists (e.g., naloxone) can paradoxically enhance eating in certain anorexic conditions.
- Opioid agonist activity can result in either hyperphagia or anorexia, depending on the receptor type involved.
Conclusions:
- Endogenous opioids and opiate receptors are critical regulators of appetite and feeding behavior.
- Opiate antagonists represent a potential therapeutic strategy for managing overeating and obesity.
- Dysregulation of opioid pathways can lead to pathological feeding states, including anorexia and hyperphagia.
- Targeting specific opiate receptor types may offer a way to normalize aberrant feeding behaviors.